Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

PERC Rule to Exclude Pulmonary Embolism in the Emergency Deparment

Condition:   Emergency Patients
Intervention:   Other: PERC based Strategy
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified February 2015

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

Conditions:   Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis;   Deep Venous Thrombosis;   Thromboembolism;   DVT
Intervention:   Drug: Warfarin
Sponsors:   University of Alberta;   Vancouver Coastal Health Research Institute
Recruiting - verified February 2015

Biomarkers in Post Thrombotic Syndrome

Conditions:   Postthrombotic Syndrome With Ulcer of Left Lower Extremity;   Extracellular Matrix Alteration
Intervention:   Procedure: Blood drawing (venipuncture)
Sponsor:   University of Cantanzaro
Completed - verified March 2015

Comparison Between a Non-elastic Falcro Device and Current Method After Total Knee Arthroplasty

Condition:   Lymphedema
Interventions:   Device: New non-elastic compression kit;   Device: current compression stocking Comprinet®
Sponsor:   Nij Smellinghe Hosptial
Not yet recruiting - verified February 2015

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified January 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified February 2015

Comparison of Topical and Intravenous Tranexamic Acid on Blood Loss and Transfusion Rates in Total Hip Arthroplasty

Condition:   Blood Loss
Interventions:   Drug: 0.9% sodium chloride;   Drug: tranexamic  acid;   Drug: tranexamic  acid
Sponsor:   Shanghai Jiao Tong University School of Medicine
Recruiting - verified December 2014

Rituximab and Belimumab for Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN)
Recruiting - verified February 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified February 2015

Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization

Conditions:   Achilles Tendon Rupture;   Deep Vein Thrombosis
Intervention:   Procedure: Controlled early mobilization
Sponsors:   Hvidovre University Hospital;   DJO Incorporated;   The Danish Rheumatism Association
Recruiting - verified February 2015

Hip Fracture Impact on Vascular Events In Noncardiac Surgery patIents: a cOhort evaluatioN (Hip VISION): Pilot Study

Condition:   Hip Fractures
Intervention:  
Sponsor:   Population Health Research Institute
Active, not recruiting - verified February 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified February 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Phenprocoumon
Sponsor:   Bayer
Recruiting - verified February 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Acenocoumarol
Sponsor:   Bayer
Recruiting - verified February 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting - verified October 2013

Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)

Condition:   Venous Thrombosis
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Completed - verified February 2015

Free DNA and Nucleosome Concentrations in Pathological Pregnancies

Conditions:   Pregnancy;   Venous Thrombosis;   Pulmonary Embolism;   Hypertension, Pregnancy-Induced;   Eclampsia;   HELLP Syndrome;   Pre-Eclampsia;   Fetal Death;   Placental Insufficiency
Interventions:   Biological: Bloodwork, baseline;   Biological: Blood work, Months 1 & 2;   Biological: Bloodwork, Months -1 to -6
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified February 2015

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

Conditions:   Deep Vein Thrombosis Leg;   Stroke (in Patients With Atrial Fibrillation)
Interventions:   Drug: DPOC-4088;   Drug: Placebo
Sponsors:   Diakron Pharmaceuticals;   Drug Research Unit Ghent, Ghent, Belgium;   Kinesis Pharma BV, Breda, the Netherlands
Terminated - verified July 2012

Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Rosuvastatin
Sponsors:   Leiden University Medical Center;   Netherlands Heart Foundation
Recruiting - verified February 2015

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Conditions:   Arterial Thromboembolic Events;   Atrial Fibrillation
Interventions:   Drug: Placebo;   Drug: Dalteparin
Sponsors:   Duke University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2015

Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults

Condition:   HIV
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2015

Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

Conditions:   Arthroplasty, Replacement, Hip;   Thrombosis
Intervention:   Drug: DU-176b
Sponsor:   Daiichi Sankyo Inc.
Completed - verified February 2015

Get CardioSmart

You're Invited